ScopeRoyal Devon University Healthcare NHS Foundation Trust
119 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Genomics Laboratory, RILD Building Level 3, Barrack Road, Exeter
Exeter EX2 5DW , United Kingdom
Exeter EX2 5DW , United Kingdom
Accreditation
Active
UKAS
8092
nhs.net
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8092
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Royal Devon University Healthcare NHS Foundation Trust
Exeter
Royal Devon University Healthcare NHS Foundation Trust
Barnstaple
Royal Devon University Healthcare NHS Foundation Trust
Exeter
Royal Devon University Healthcare NHS Foundation Trust
Exeter
Royal Devon University Healthcare NHS Foundation Trust
Barnstable
Test Capabilities (119)
| Standard Reference | Description | Category |
|---|---|---|
| HLA B27 | HLA-B27 | Biocompatibility (ISO 10993) |
| CADASIL (NOTCH3) | CADASIL (NOTCH3) | Molecular Diagnostics / PCR |
| Glucose-Galactose Malabsorption (SLC5A1) | Glucose-Galactose-Malabsorption (SLC5A1) | Molecular Diagnostics / PCR |
| 1 & 4 (MEN1, CDKN1B) | 1 & 4 (MEN1, CDKN1B) | Other |
| 11p15 maternal loss of heterozygosity testing in pancreatic tissue | 11p15 maternal loss of heterozygosity testing in pancreatic tissue | Other |
| Aarskog-Scott syndrome (FGD1) | Aarskog-Scott syndrome (FGD1) | Other |
| Acrodysostosis (PRKAR1A & PDE4D) | Acrodysostosis (PRKAR1A & PDE4D) | Other |
| Acute promyelocytic leukaemia (t(15;17)) | Acute promyelocytic leukaemia (t(15;17)) | Other |
| Alagille syndrome (JAG1, NOTCH2) | Alagille syndrome (JAG1, NOTCH2) | Other |
| Alveolar Capillary with Misalignment of Pulmonary Veins (FOXF1) | Alveolar Capillary with Misalignment of Pulmonary Veins (FOXF1) | Other |
| Anaemia (SLC19A2) | Anaemia (SLC19A2) | Other |
| Aortic Valve disease (NOTCH1) | Aortic Valve disease (NOTCH1) | Other |
| Atypical Progeriod Syndrome (LMNA) Molecular Genetics | Atypical Progeriod Syndrome (LMNA) Molecular Genetics | Other |
| B-cell clonality (IgH, IgK, IgL) | B-cell clonality (IgH, IgK, IgL) | Other |
| BCR-ABL kinase domain sequencing (BCR-ABL) | BCR-ABL kinase domain sequencing (BCR-ABL) | Other |
| Bosley-Salih-Alorainy syndrome (HOXA1, HOXB1) | Bosley-Salih-Alorainy syndrome (HOXA1, HOXB1) | Other |
| Brain Small-Vessel Disease with Haemorrhage (COL4A1 & COL4A2) | Brain Small-Vessel Disease with Haemorrhage (COL4A1 & COL4A2) | Other |
| Carney Complex (PRKAR1A) | Carney Complex (PRKAR1A) | Other |
| Charcot-Marie-Tooth hereditary neuropathy type 2B1 (LMNA) | Charcot-Marie-Tooth hereditary neuropathy type 2B1 (LMNA) | Other |
| Chondrodysplasia punctata (EBP, ARSE, PEX7, GNPAT, AGPS) | Chondrodysplasia punctata (EBP, ARSE, PEX7, GNPAT, AGPS) | Other |
| Chronic Neutrophilic Leukaemia and Atypical CML (CSF3R) | Chronic Neutrophilic Leukaemia and Atypical CML (CSF3R) | Other |
| Chronic lymphocytic leukaemia (TP53, RB1 / DLEU / MIRN15A-16 region, ATM, trisomy 12) | Chronic lymphocytic leukaemia (TP53, RB1 / DLEU / MIRN15A-16 region, ATM, trisomy 12) | Other |
| Cole Disease (ENPP1) | Cole Disease (ENPP1) | Other |
| Combined Pituitary Hormone deficiency (HESX1, POU1F1, PROP1, LHX3, LHX4) | Combined Pituitary Hormone deficiency (HESX1, POU1F1, PROP1, LHX3, LHX4) | Other |
| Cone Rod Dystrophy (GUCY2D ) | Cone Rod Dystrophy (GUCY2D ) | Other |
| Congenital Fibrosis of the extraocular muscles (KIF21A, PHOX2A, TUBB3) | Congenital Fibrosis of the extraocular muscles (KIF21A, PHOX2A, TUBB3) | Other |
| Congenital Generalised lipodystrophy type 1 (AGPAT2, BSCL2, CAV1, PPARG, PTRF) | Congenital Generalised lipodystrophy type 1 (AGPAT2, BSCL2, CAV1, PPARG, PTRF) | Other |
| Congenital abnormalities of the kidney and urinary tract and VACTERL (TRAP1) Molecular Genetics | Congenital abnormalities of the kidney and urinary tract and VACTERL (TRAP1) Molecular Genetics | Other |
| Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD) syndrome (NSDHL) | Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD) syndrome (NSDHL) | Other |
| Congenital hypothyroidism (FOXE1, NKX2-1, PAX8, TSHR, TPO, TG, DUOX2, THRA) | Congenital hypothyroidism (FOXE1, NKX2-1, PAX8, TSHR, TPO, TG, DUOX2, THRA) | Other |
| Cystic Fibrosis (CFTR) – screen for 38 mutations | Cystic Fibrosis (CFTR) – screen for 38 mutations | Other |
| Deficiency (GH1, GHRHR) | Deficiency (GH1, GHRHR) | Other |
| Detection of Rhesus D fetal genotype using circulating cell free DNA | Detection of Rhesus D fetal genotype using circulating cell free DNA | Other |
| Detection of clinically relevant nucleic acid sequence variants | Detection of clinically relevant nucleic acid sequence variants | Other |
| Detection of clinically relevant nucleic acid sequence variants Molecular Genetics | Detection of clinically relevant nucleic acid sequence variants Molecular Genetics | Other |
| Dilated Cardiomyopathy type 1A (LMNA) | Dilated Cardiomyopathy type 1A (LMNA) | Other |
| Duane Retraction Syndrome (CHN1) | Duane Retraction Syndrome (CHN1) | Other |
| Duane radial ray syndrome (Okihiro syndrome) (SALL4) | Duane radial ray syndrome (Okihiro syndrome) (SALL4) | Other |
| Emery Dreifuss Muscular Dystrophy (LMNA) | Emery Dreifuss Muscular Dystrophy (LMNA) | Other |
| Exome sequencing | Exome sequencing | Other |
| Familial Glucocorticoid deficiency (MC2R, MCM4, MRAP, NNT, STAR) | Familial Glucocorticoid deficiency (MC2R, MCM4, MRAP, NNT, STAR) | Other |
| Familial Hepatic Adenomas due to bi-allelic inactivation of HNF1A (HNF1A) Molecular Genetics | Familial Hepatic Adenomas due to bi-allelic inactivation of HNF1A (HNF1A) Molecular Genetics | Other |
| Familial Hyperparathyroidism (MEN1, CASR, CDC73, CDKN1A, CDKN1B, CDKN2B, CDKN2C, RET) | Familial Hyperparathyroidism (MEN1, CASR, CDC73, CDKN1A, CDKN1B, CDKN2B, CDKN2C, RET) | Other |
| Familial Hypoparathyroidism (CASR, GCM2, GNA11, PTH) | Familial Hypoparathyroidism (CASR, GCM2, GNA11, PTH) | Other |
| Familial Isolated Pituitary Adenoma (AIP) | Familial Isolated Pituitary Adenoma (AIP) | Other |
| Familial Porencephaly (COL4A1, COL4A2, JAM3) | Familial Porencephaly (COL4A1, COL4A2, JAM3) | Other |
| Familial hypocalciuric hypercalcaemia (AP2S1, GNA11, CASR) | Familial hypocalciuric hypercalcaemia (AP2S1, GNA11, CASR) | Other |
| Familial partial lipodystrophy (LMNA, PPARG, PLIN1) | Familial partial lipodystrophy (LMNA, PPARG, PLIN1) | Other |
| Fanconi-Bickel syndrome (SLC2A2) | Fanconi-Bickel syndrome (SLC2A2) | Other |
| Feingold Syndrome (MYCN, MIR17HG) | Feingold Syndrome (MYCN, MIR17HG) | Other |
| Follicle centre cell lymphoma (t(14;18)) | Follicle centre cell lymphoma (t(14;18)) | Other |
| Gastrointestinal atresia (CFAP53, CHD7, FANCB, FANCC, GLI3, MID1, MYCN, RFX6, SOX2, TTC7A, EFTUD2, FOXF1) | Gastrointestinal atresia (CFAP53, CHD7, FANCB, FANCC, GLI3, MID1, MYCN, RFX6, SOX2, TTC7A, EFTUD2, FOXF1) | Other |
| Generalised Arterial Calcification of Infancy (ABCC6, ENPP1, NT5E) Molecular Genetics | Generalised Arterial Calcification of Infancy (ABCC6, ENPP1, NT5E) Molecular Genetics | Other |
| Haemochromatosis (HFE) | Haemochromatosis (HFE) | Other |
| Hairy Cell Leukaemia (BRAF) | Hairy Cell Leukaemia (BRAF) | Other |
| Hajdu-Cheney Syndrome (NOTCH2) | Hajdu-Cheney Syndrome (NOTCH2) | Other |
| Hanac Syndrome (COL4A1) | Hanac Syndrome (COL4A1) | Other |
| Hereditary Phaeochromocytoma / paraganglioma (RET, VHL, SDHB, SDHC, SDHD, SDHAF2, TMEM127, MAX, FH, SDHA) | Hereditary Phaeochromocytoma / paraganglioma (RET, VHL, SDHB, SDHC, SDHD, SDHAF2, TMEM127, MAX, FH, SDHA) | Other |
| Hirschsprung disease (RET) | Hirschsprung disease (RET) | Other |
| Holoprosencephaly (GLI2, PTCH1, SHH, SIX3, TGIF1, ZIC2) | Holoprosencephaly (GLI2, PTCH1, SHH, SIX3, TGIF1, ZIC2) | Other |
| Horizontal gaze palsy with progressive scoliosis (ROBO3) | Horizontal gaze palsy with progressive scoliosis (ROBO3) | Other |
| Hyperinsulinism (ABCC8, KCNJ11, HNF4A, GLUD1, GCK, HADH) | Hyperinsulinism (ABCC8, KCNJ11, HNF4A, GLUD1, GCK, HADH) | Other |
| Hyperphoshatemic familial tumoral calcinosis (GALNT3, FGF23, KL, SAMD9) | Hyperphoshatemic familial tumoral calcinosis (GALNT3, FGF23, KL, SAMD9) | Other |
| Hyperthyroidism & Congenital | Hyperthyroidism & Congenital | Other |
| Hypophosphatemic rickets (PHEX, FGF23, DMP1, ENPP1) Molecular Genetics | Hypophosphatemic rickets (PHEX, FGF23, DMP1, ENPP1) Molecular Genetics | Other |
| Hypophosphatemic rickets with Hypercalciuria (SLC34A3) | Hypophosphatemic rickets with Hypercalciuria (SLC34A3) | Other |
| Hypothyroidism (GLIS3) | Hypothyroidism (GLIS3) | Other |
| Hypothyroidism (TSHR) | Hypothyroidism (TSHR) | Other |
| IPEX Syndrome (FOXP3) | IPEX Syndrome (FOXP3) | Other |
| Inherited thrombophilia (F5, F2) | Inherited thrombophilia (F5, F2) | Other |
| Isolated Growth Hormone | Isolated Growth Hormone | Other |
| Kallmann syndrome (KAL1, FGFR1, FGF8, PROKR2, PROK2) | Kallmann syndrome (KAL1, FGFR1, FGF8, PROKR2, PROK2) | Other |
| Limb Girdle Muscular Dystrophy type 1b (LMNA) | Limb Girdle Muscular Dystrophy type 1b (LMNA) | Other |
| MELAS (mitochondrial m.3243A>G mutation) | MELAS (mitochondrial m.3243A>G mutation) | Other |
| Malignant Melanoma (BRAF) | Malignant Melanoma (BRAF) | Other |
| Mandibuloacral Dysplasia (ZMPSTE24, LMNA, POLD1) | Mandibuloacral Dysplasia (ZMPSTE24, LMNA, POLD1) | Other |
| Mandibulofacial dysostosis with microcephaly (EFTUD2, SF3B4) | Mandibulofacial dysostosis with microcephaly (EFTUD2, SF3B4) | Other |
| Mantle cell lymphoma (Cyclin D1) | Mantle cell lymphoma (Cyclin D1) | Other |
| Mantle cell lymphoma (t(11;14)) | Mantle cell lymphoma (t(11;14)) | Other |
| Maternal Cell Contamination & | Maternal Cell Contamination & | Other |
| Maturity-onset diabetes of the young (MODY) (GCK, HNF1A, HNF4A) Molecular Genetics | Maturity-onset diabetes of the young (MODY) (GCK, HNF1A, HNF4A) Molecular Genetics | Other |
| Medullary Thyroid Carcinoma (RET, RAS) | Medullary Thyroid Carcinoma (RET, RAS) | Other |
| Metastatic colorectal cancer (KRAS, NRAS, BRAF) | Metastatic colorectal cancer (KRAS, NRAS, BRAF) | Other |
| Mobius syndrome (PLXND1, REV3L) | Mobius syndrome (PLXND1, REV3L) | Other |
| Molecular Genetics | Molecular Genetics | Other |
| Molecular Genetics examination activities for the purpose of clinical diagnosis | Molecular Genetics examination activities for the purpose of clinical diagnosis | Other |
| Multiple Endocrine Neoplasia type 2 (RET) | Multiple Endocrine Neoplasia type 2 (RET) | Other |
| Multiple Endocrine Neoplasia types | Multiple Endocrine Neoplasia types | Other |
| Multiple Exostosis (EXT1, EXT2) | Multiple Exostosis (EXT1, EXT2) | Other |
| Myeloproliferative disorders (JAK2, MPL, CALR) | Myeloproliferative disorders (JAK2, MPL, CALR) | Other |
| Name of disease with name of analysed gene(s) in brackets | Name of disease with name of analysed gene(s) in brackets | Other |
| Neonatal Diabetes (ABCC8, KCNJ11, INS) | Neonatal Diabetes (ABCC8, KCNJ11, INS) | Other |
| Neonatal Diabetes and Congenital | Neonatal Diabetes and Congenital | Other |
| Neonatal Diabetes with Pancreatic and cerebellar agenesis (PTF1A) | Neonatal Diabetes with Pancreatic and cerebellar agenesis (PTF1A) | Other |
| Nestor-Guillermo Progeria | Nestor-Guillermo Progeria | Other |
| Non-Small cell lung cancer (EGFR) | Non-Small cell lung cancer (EGFR) | Other |
| Non-invasive prenatal diagnosis for monogenic diabetes | Non-invasive prenatal diagnosis for monogenic diabetes | Other |
| Pontocerebellar hypoplasia (AMPD2, CASK, CHMP1A, CLP1, EXOSC3, PCLO, RARS2, SEPSECS, TSEN2, TSEN34, TSEN54, VPS53, VRK1) | Pontocerebellar hypoplasia (AMPD2, CASK, CHMP1A, CLP1, EXOSC3, PCLO, RARS2, SEPSECS, TSEN2, TSEN34, TSEN54, VPS53, VRK1) | Other |
| Prediction of 5-fluorouracil toxicity (DPYD) | Prediction of 5-fluorouracil toxicity (DPYD) | Other |
| Prediction of Irinotecan toxicity (UGT1A1) Molecular Genetics | Prediction of Irinotecan toxicity (UGT1A1) Molecular Genetics | Other |
| Primary pigmented nodular adrenocortical disease (PRKAR1A, PDE8B, PDE11A) | Primary pigmented nodular adrenocortical disease (PRKAR1A, PDE8B, PDE11A) | Other |
| Pseudohypoaldosteronism type 2 (WNK1, WNK4, CUL3, KLHL3) | Pseudohypoaldosteronism type 2 (WNK1, WNK4, CUL3, KLHL3) | Other |
| Pseudoxanthoma elasticum (ABCC6 & ENPP1) | Pseudoxanthoma elasticum (ABCC6 & ENPP1) | Other |
| Pyridoxine dependent epilepsy (ALDH7A1) | Pyridoxine dependent epilepsy (ALDH7A1) | Other |
| Renal Cysts & Diabetes (RCAD) | Renal Cysts & Diabetes (RCAD) | Other |
| Restrictive Dermopathy (ZMPSTE24, LMNA) | Restrictive Dermopathy (ZMPSTE24, LMNA) | Other |
| SHORT syndrome (PIK3R1) | SHORT syndrome (PIK3R1) | Other |
| Specimen Source Identification | Specimen Source Identification | Other |
| Spondylocostal Dysostosis (DLL3, MESP2, LFNG, HES7, TBX6, RIPPLY2) | Spondylocostal Dysostosis (DLL3, MESP2, LFNG, HES7, TBX6, RIPPLY2) | Other |
| Syndrome (BANF1) | Syndrome (BANF1) | Other |
| Syndrome (HNF1B) | Syndrome (HNF1B) | Other |
| Systemic mastocytosis (KIT) | Systemic mastocytosis (KIT) | Other |
| T-cell clonality (TCRg, TCRb, TCRd) | T-cell clonality (TCRg, TCRb, TCRd) | Other |
| Thiamine Responsive Megaloblastic | Thiamine Responsive Megaloblastic | Other |
| Thyroid hormone resistance (THRB) | Thyroid hormone resistance (THRB) | Other |
| Visceral Heterotaxy (CFC1, ZIC3) | Visceral Heterotaxy (CFC1, ZIC3) | Other |
| Waldenstrom’s Macroglobulinemia (MYD88) Molecular Genetics | Waldenstrom’s Macroglobulinemia (MYD88) Molecular Genetics | Other |
| Werner Syndrome (WRN) | Werner Syndrome (WRN) | Other |
| X-linked Acrogigantism (GPR101) | X-linked Acrogigantism (GPR101) | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.